FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
COVID-19 will remain a pandemic as it continues to constitute a public health emergency of international concern, the WHO’s highest form of an.
Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.
There is a predominance of Omicron BA. 5.2 and BF.7 Covid-19 lineages, accounting for 97.5% of all local infections in China, according to.